Daniel Chard Insider Profile
4 Followers
Daniel Chard, Chairman & CEO, Director at Medifast, holds 355.61K shares in Medifast (Ticker: MED), holds 48.11K shares in Nu Skin (Ticker: NUS).
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-13.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel Chard holds in companies
Most Profitable Insider Trade
The most profitable trade made by Daniel Chard
Daniel Chard's Trading History
Medifast
Mar 27, 2026
Chairman & CEO, Director
Uninformative Buy
―
$4.51M
Nu Skin
Jul 08, 2015
Pres Global Sales & Operations
Uninformative Sell
816.73K
$232.38K
List of latest transactions for each holding click on a transaction to see Daniel Chard's performance on stock
You May Also Like
Daniel Chard insider profile FAQ
What is the percentage of profitable transactions made by Daniel Chard?
The percentage of profitable transactions made by Daniel Chard is 33%.
What is the average return per transaction made by Daniel Chard?
The average return per transaction made by Daniel Chard is -13.70%.
What stocks does Daniel Chard hold?
Daniel Chard holds: MED, NUS stocks.
What was Daniel Chard’s latest transaction?
Daniel Chard latest transaction was an Uninformative Buy of ―.
What was Daniel Chard's most profitable transaction?
Daniel Chard’s most profitable transaction was an Informative Buy of MED stock on March 27, 2026. The return on the trade was 24.90%.
What is Daniel Chard's role in Medifast?
Daniel Chard's role in Medifast is Chairman & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.